Stockreport

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vivani Medical, Inc.  (VANI) 
PDF Strategic shift prioritizes the development of GLP-1 implants for the treatment of obesity and chronic weight managementPositive NPM-115 (exenatide implant) preclinical [Read more]